Wave Life Sciences Files 8-K
Ticker: WVE · Form: 8-K · Filed: Nov 20, 2024 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory, financial-reporting
TL;DR
Wave Life Sciences filed an 8-K on Nov 20, 2024. Standard disclosure.
AI Summary
Wave Life Sciences Ltd. filed an 8-K on November 20, 2024, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's incorporation in Singapore and provides business and mailing addresses in Singapore and Cambridge, MA.
Why It Matters
This 8-K filing provides official updates and disclosures from Wave Life Sciences Ltd. to the SEC, informing investors about the company's regulatory compliance and financial reporting status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not contain specific material events that would inherently increase risk.
Key Numbers
- 001-37627 — Commission File Number (SEC identifier for Wave Life Sciences Ltd.)
- 98-1356880 — IRS Employer Identification No. (Tax identification for the company.)
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- November 20, 2024 (date) — Date of Report
- Singapore (location) — Jurisdiction of Incorporation and Business Address
- Cambridge, MA (location) — Mailing Address
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, detailing Regulation FD Disclosures and Financial Statements and Exhibits.
When was this 8-K report filed?
The report was filed on November 20, 2024.
Where is Wave Life Sciences Ltd. incorporated?
Wave Life Sciences Ltd. is incorporated in Singapore.
What are the business and mailing addresses provided in the filing?
The business address is 7 Straits View #12-00, Marina One East Tower, Singapore 018936, and the mailing address is 733 Concord Avenue, Cambridge, MA 02138.
What is the SIC code for Wave Life Sciences Ltd.?
The Standard Industrial Classification (SIC) code for Wave Life Sciences Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 546 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-11-20 06:05:04
Key Financial Figures
- $0 — of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d868125d8k.htm (8-K) — 25KB
- d868125dex991.htm (EX-99.1) — 41KB
- g868125ex99_1p10g1.jpg (GRAPHIC) — 156KB
- g868125ex99_1p11g1.jpg (GRAPHIC) — 213KB
- g868125ex99_1p12g1.jpg (GRAPHIC) — 250KB
- g868125ex99_1p13g1.jpg (GRAPHIC) — 230KB
- g868125ex99_1p14g1.jpg (GRAPHIC) — 157KB
- g868125ex99_1p15g1.jpg (GRAPHIC) — 234KB
- g868125ex99_1p16g1.jpg (GRAPHIC) — 253KB
- g868125ex99_1p17g1.jpg (GRAPHIC) — 225KB
- g868125ex99_1p18g1.jpg (GRAPHIC) — 257KB
- g868125ex99_1p19g1.jpg (GRAPHIC) — 234KB
- g868125ex99_1p1g1.jpg (GRAPHIC) — 355KB
- g868125ex99_1p20g1.jpg (GRAPHIC) — 199KB
- g868125ex99_1p21g1.jpg (GRAPHIC) — 136KB
- g868125ex99_1p22g1.jpg (GRAPHIC) — 322KB
- g868125ex99_1p23g1.jpg (GRAPHIC) — 205KB
- g868125ex99_1p24g1.jpg (GRAPHIC) — 295KB
- g868125ex99_1p25g1.jpg (GRAPHIC) — 263KB
- g868125ex99_1p26g1.jpg (GRAPHIC) — 235KB
- g868125ex99_1p27g1.jpg (GRAPHIC) — 166KB
- g868125ex99_1p28g1.jpg (GRAPHIC) — 142KB
- g868125ex99_1p29g1.jpg (GRAPHIC) — 312KB
- g868125ex99_1p2g1.jpg (GRAPHIC) — 363KB
- g868125ex99_1p30g1.jpg (GRAPHIC) — 287KB
- g868125ex99_1p31g1.jpg (GRAPHIC) — 230KB
- g868125ex99_1p32g1.jpg (GRAPHIC) — 202KB
- g868125ex99_1p33g1.jpg (GRAPHIC) — 273KB
- g868125ex99_1p34g1.jpg (GRAPHIC) — 193KB
- g868125ex99_1p35g1.jpg (GRAPHIC) — 146KB
- g868125ex99_1p36g1.jpg (GRAPHIC) — 253KB
- g868125ex99_1p37g1.jpg (GRAPHIC) — 177KB
- g868125ex99_1p38g1.jpg (GRAPHIC) — 175KB
- g868125ex99_1p3g1.jpg (GRAPHIC) — 267KB
- g868125ex99_1p4g1.jpg (GRAPHIC) — 243KB
- g868125ex99_1p5g1.jpg (GRAPHIC) — 331KB
- g868125ex99_1p6g1.jpg (GRAPHIC) — 273KB
- g868125ex99_1p7g1.jpg (GRAPHIC) — 223KB
- g868125ex99_1p8g1.jpg (GRAPHIC) — 159KB
- g868125ex99_1p9g1.jpg (GRAPHIC) — 295KB
- 0001193125-24-262067.txt ( ) — 12509KB
- wve-20241120.xsd (EX-101.SCH) — 3KB
- wve-20241120_lab.xml (EX-101.LAB) — 18KB
- wve-20241120_pre.xml (EX-101.PRE) — 11KB
- d868125d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following exhibit relating to Item 7.01 is furnished and not filed: Exhibit No. Description 99.1 Corporate Presentation of Wave Life Sciences Ltd. dated November 20, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Kyle Moran Kyle Moran Chief Financial Officer Date: November 20, 2024